Brokerages Set Dyne Therapeutics, Inc. (NASDAQ:DYN) PT at $48.85
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have been given a consensus rating of “Buy” by the fifteen analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, twelve have given a buy recommendation and two have assigned a strong buy recommendation […]
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have been given a consensus rating of “Buy” by the fifteen analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, twelve have given a buy recommendation and two have assigned a strong buy recommendation […]
